ArticleGynecologic oncology2012

The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.

Iris L Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.